Identification and characterization of peptides and proteins in doping control analysis

Current Proteomics

Volumn 2, Issue 3, 2005, Pages 191-208

  Thevis, Mario ^a   Schänzer, Wilhelm ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

Author keywords

Doping; Erythropoietin; Growth hormone; Insulin; Mass spectrometry; Oxygen carriers; Sport

Indexed keywords

EID: 28844488390     PISSN: 15701646     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016405774641147     Document Type: Review

References (103)

1. Alma, C., Trout, G., Woodland, N. and Kazlauskas, R. (2002). Detection of haemoglobin based oxygen carriers. In Recent Advances in Doping Analysis, (eds. W. Schänzer, H. Geyer, A. Gotzmann and U. Mareck), Sport&Buch Strauß, Cologne, pp. 169-78.
2. Baumann, G. (1991). Growth hormone heterogeneity: Genes, isohormones, variants, and binding proteins. Endocr. Rev. 12: 424-49.
3. Baumann, G. (1999). Growth hormone heterogeneity in human pituitary and plasma. Horm. Res. 51: 2-6.
4. Bauman, W.A. and Yalow, R.S. (1981). Insulin as a lethal weapon. J. Forensic Sci. 26: 594-98.
5. Baumann, G., Stolar, M.W. and Amburn, K. (1985). Molecular forms of circulating growth hormone during spontaneous secretory episodes and in the basal state. J. Clin. Endocrinol. Metab. 60: 1216-20.
6. Baumann, G., Stolar, M.W. and Buchanan, T.A. (1986). The metabolic clearance, distribution, and degradation of dimeric and monomeric growth hormone (GH): Implications for the pattern of circulating GH forms. Endocrinology 119: 1497-501.
7. Becker, G.W., Bowsher, R.R., Mackellar, W.C., Poor, M.L., Tackitt, P.M. and Riggin, R.M. (1987). Chemical, physical, and biological characterization of a dimeric form of biosynthetic human growth hormone. Biotechnol. Appl. Biochem. 9: 478-87.
8. Berggren, A., Ehrnborg, C., Rosen, T., Ellegard, L., Bengtsson, B. and Caidahl, K. (2005). Short-term administration of supraphysiologic rHGH does not increase maximum endurance exercise capacity in healthy, active young men and women with normal GH-IGF-1 axes. J. Clin. Endocrinol. Metab. 90: 3268-73.
9. Bidlingmaier, M., Wu, Z. and Strasburger, C.J. (2000). Test method: GH. Baillieres Clin. Endocrinol. Metab. 14: 99-109.
10. Bidlingmaier, M., Wu, Z. and Strasburger, C.J. (2001). Doping with growth hormone. J. Pediatr. Endocrinol. Metab. 14: 1077-84.
11. Bidlingmaier, M., Wu, Z. and Strasburger, C. (2003). Problems with gh doping in sports. J. Endocrinol. Invest. 26: 924-31.
12. Birkinshaw, V.J., Gurd, M.R., Randall, S.S., Curry, A.S., Price, D.E. and Wright, P.H. (1958). Investigations in a case of murder by insulin poisoning. Br. Med. J. 34: 463-8.
13. Brostedt, P., Luthman, M., Wide, L., Werner, S. and Roos, P. (1990). Characterization of dimeric forms of human pituitary growth hormone by bioassay, radioreceptor assay, and radioimmunoassay. Acta Endocrinol. (Copenh) 122: 241-8.
14. Brostedt, P. and Roos, P. (1989). Isolation of dimeric forms of human pituitary growth hormone. Prep. Biochem. 19: 217-29.
15. Bunn, F.H., Esham, W.T. and Bull, R.W. (1969). The renal handling of hemoglobin. I. Glomerular filtration. J. Exp. Med. 129: 909-24.
16. Caldini, A., Moneti, G., Fanelli, A., Bruschettini, A., Mercurio, S., Pieraccini, G., Cini, E., Ognibene, A., et al. (2003). Epoetin alpha, epoetin beta and darbepoetin alfa: Two- dimensional gel electrophoresis isoforms characterization and mass spectrometry analysis. Proteomics 3: 937-41.
17. Cohn, S. (2000). Blood substitutes in surgery. Surgery 127: 599-602.
18. Darby, S.M., Miller, M.L., Allen, R.O. and LeBeau, M. (2001). A mass spectrometric method for quantitation of intact insulin in blood samples. J. Anal. Toxicol. 25: 8-14.
19. de Francisco, A. (2003). Subcutaneous cera (continuous erythropoiesis receptor activator) has potent erythropoietic activity in dialysis patients with chronic renal failure; an exploratory multiple-dose study. Oral Presentation 15th November 2003; American Society of Nephrology, San Diego, USA.
20. DeNoto, F.M., Moore, D.D. and Goodman, H.M. (1981). Human growth hormone DNA sequence and mma structure: Possible alternative splicing. Nucleic Acids Res. 9: 3719-30.
21. Dordal, M.S., Wang, F.F. and Goldwasser, E. (1985). The role of carbohydrate in erythropoietin action. Endocrinology 116: 2293-9.
22. Egrie, J.C. and Browne, J.K. (2001). Development and characterization of novel erythropoiesis stimulating protein (NESP). Br. J. Cancer 84: 3-10.
23. Ehrnborg, C., Ellegard, L., Bosaeus, I., Bengtsson, B.A. and Rosen, T. (2005). Supraphysiological growth hormone: Less fat, more extracellular fluid but uncertain effects on muscles in healthy, active young adults. Clin. Endocrinol. 62: 449-57.
24. Evans, P.J. and Lynch, R.M. (2003). Insulin as a drug of abuse in body building. Br. J. Sports Med. 37: 356-57.
25. Gasthuys, M., Alves, S., Fenaille, F. and Tabet, J.C. (2004). Simple identification of a cross-linked hemoglobin by tandem mass spectrometry in human serum. Anal. Chem. 76: 6628-34.
26. Gasthuys, M., Alves, S. and Tabet, J. (2005). N-terminal adducts of bovine hemoglobin with glutaraldehyde in a hemoglobin-based oxygen carrier. Anal. Chem. 77: 3372-78.
27. Giorgianni, F., Beranova-Giorgianni, S. and Desiderio, D.M. (2004). Identification and characterization of phosphorylated proteins in the human pituitary. Proteomics 4: 587-98.
28. Goebel, C., Alma, C., Howe, C., Kazlauskas, R. and Trout, G. (2005a). Methodologies for detection of hemoglobin-based oxygen carriers. J. Chromatogr. Sci. 43: 39-46.
29. Goebel, C., Alma, C., Trout, G. and Kazlauskas, R. (2005b). HBOC detection - progress since 2000. In Recent Advances in Doping Analysis, (eds. W. Schänzer, H. Geyer, A. Gotzmann and U. Mareck), Sport und Buch Strauß, Cologne, in press.
30. Gotzmann, A., Voss, S., Machnik, M. and Schänzer, W. (2002). Detection of hemopure and hemoglobin in human plasma by HPLC/UV and different types of columns - an approach to screen for this substance in doping analysis. In Recent Advances in Doping Analysis, (eds. W. Schänzer, H. Geyer, A. Gotzmann and U. Mareck), Sport und Buch Strauß, Cologne, 179-87.
31. Greenburg, A. and Kim, H. (2004). Hemoglobin-based oxygen carriers. Crit Care. 8: S61-S64.
32. Grigorian, A., Bustamante, J., Hernandez, P., Martinez, A. and Haro, L. (2005). Extraordinarily stable disulfide-linked homodimer of human growth hormone. Protein Sci. 14: 902-13.
33. Haibach, H., Dix, J.D. and Shah, J.H. (1987). Homicide by insulin administration. J. Forensic Sci. 32: 208-16.
34. Healy, M.L., Gibney, J., Russell-Jones, D.L., Pentecost, C., Croos, P., Sonksen, P.H. and Umpleby, A.M. (2003). High dose growth hormone exerts an anabolic effect at rest and during exercise in endurance-trained athletes. J. Clin. Endocrinol. Metab. 88: 5221-6.
35. Healy, M.L., Dall, R., Gibney, J., Bassett, E., Ehrnborg, C., Pentecost, C., Rosen, T., Cittadini, A., et al. (2005). Toward the development of a test for growth hormone (gh) abuse: A study of extreme physiological ranges of gh-dependent markers in 813 elite athletes in the postcompetition setting. J. Clin. Endocrinol. Metab. 90: 641-9.
36. Hepner, F., Cszasar, E., Roitinger, E. and Lubec, G. (2005). Mass spectrometrical analysis of recombinant human growth hormone (genotropin(r)) reveals amino acid substitutions in 2% of the expressed protein. Proteome Sci. 3: 1.
37. Hokke, C.H., Bergwerff, A.A., Van Dedem, G.W.K., Kamerling, J.P. and Vliegenthart, J.F.G. (1995). Structural analysis of the sialylated n- and o-linked carbohydrate chains of recombined human erythropoietin expressed in chinese hamster ovary cells sialylation patterns and brach location of dimeric n-acetyllactoseamine units. Eur. J. Biochem. 228: 981-1008.
38. Jelkmann, W. (2004). Molecular biology of erythropoietin. Intern. Med. 43: 649-59.
39. Jenkins, P. (1999). Growth hormone and exercise. Clin. Endocrinol. 50: 683-89.
40. Kawasaki, N., Haishima, Y., Ohta, M., Itoh, S., Hyuga, M., Hyuga, S. and Hayakawa, T. (2001). Structural analysis of sulfated n-linked oligosaccharides in erythropoietin. Glycobiology 11: 1043-9.
41. Kawasaki, N., Ohta, M., Hyuga, S., Hyuga, M. and Hayakawa, T. (2000). Application of liquid chromatography/mass spectrometry and liquid chromatography with tandem mass spectrometry to the analysis of the site-specific carbohydrate heterogeneity in erythropoietin. Anal. Biochem. 285: 82-91.
42. Kazlauskas, R., Howe, C. and Trout, G. (2002). Strategies for rhEPO detection in sport. Clin. J. Sport Med. 12: 229-35.
43. Khan, A., Grinyer, J., Truong, S.T., Breen, E.J. and Packer, N.H. (2005). New urinary EPO drug testing method using two-dimensional gel electrophoresis. Clin. Chim. Acta 358: 119-130.
44. Kniess, A., Ziegler, E., Kratzsch, J., Thieme, D. and Müller, R.K. (2003). Potential parameters for the detection of HGH doping. Anal. Bioanal. Chem. 376: 696-700.
45. Kochendoerfer, G.G., Chen, S.-Y., Mao, F., Cressman, S., Traviglia, S., Shao, H., Hunter, C.L., Low, D., et al. (2003). Design and chemical synthesis of a homogeneous polymer-modified erythropoiesis protein. Science 299: 884-7.
46. Lasne, F. (2001). Double-blotting: A solution to the problem of non-specific binding of secondary antibodies in immunoblotting procedures. J. Immunol. Methods 253: 125-31.
47. Lasne, F. (2003). Double-blotting: A solution to the problem of nonspecific binding of secondary antibodies in immunoblotting procedures. J. Immunol. Methods 276: 223-6.
48. Lasne, F. and de Ceaurriz, J. (2000). Recombinant erythropoietin in urine. Nature 405: 635.
49. Lasne, F., Martin, L., Crepin, N. and de Ceaurriz, J. (2002). Detection of isoelectric profiles of erythropoietin in urine: Differentiation of natural and administered recombinant hormones. Anal. Biochem. 311: 119-26.
50. Lasne, F., Crepin, N., Ashenden, M., Audran, M. and de Ceaurriz, J. (2004). Detection of hemoglobin-based oxygen carriers in human serum for doping analysis: Screening by electrophoresis. Clin. Chem. 50: 410-5.
51. Lewis, U.J., Peterson, S.M., Bonewald, L.F., Seavey, B.K. and VanderLaan, W.P. (1977). An interchain disulfide dimer of human growth hormone. J. Biol. Chem. 252: 3697-702.
52. Lewis, U.J., Singh, R.N., Bonewald, L.F., Lewis, L.J. and Vanderlaan, W.P. (1979). Human growth hormone: Additional members of the complex. Endocrinology 104: 1256-65.
53. Lewis, U.J., Singh, R.N., Bonewald, L.F. and Seavey, B.K. (1981). Altered proteolytic cleavage of human growth hormone as a result of deamidation. J. Biol. Chem. 256: 11645-50.
54. Li, C.H. and Papkoff, H. (1956). Preparation and properties of growth hormone from human and monkey pituitary glands. Science 124: 1293-4.
55. Masuda, N., Watahiki, M., Tanaka, M., Yamakawa, M., Shimizu, K., Nagai, J. and Nakashima, K. (1988). Molecular cloning of cDNA encoding 20 kDa variant human growth hormone and the alternative splicing mechanism. Biochim. Biophys. Acta 949: 125-31.
56. Miyake, T., Kung, C.K. and Goldwasser, E. (1977). Purification of human erythropoietin. J. Biol. Chem. 252: 5558-64.
57. Moffat, A.S. (1991). Three li'l pigs and the hunt for blood substitutes. Science 253: 32-34.
58. Momomura, S., Hashimoto, Y., Shimazaki, Y. and Irie, M. (2000). Detection of exogenous growth hormone (GH) administration by monitoring ratio of 20kDa- and 22kDa-GH in serum and urine. Endocrine J. 47: 97-101.
59. Nagatomi, Y., Ikeda, M., Uchida, H., Wada, M., Kobayashi, H., Hashimoto, Y., Mabuchi, K., Hayakawa, M., et al. (2000). Reversible dimerization of 20 kilodalton human growth hormone (HGH). Growth Horm. IGF Res. 10: 207-14.
60. Nissen-Lie, G., Birkeland, K., Hemmersbach, P. and Skibeli, V. (2003). Serum stfr levels may indicate charge profiling of urinary r-hEPO in doping control. Med. Sci. Sports Exerc. 36: 588-93.
61. Ohta, M., Kawasaki, N., Hyuga, S., Hyuga, M. and Hayakawa, T. (2001). Selective glycopeptide mapping of erythropoietin by on-line high-performance liquid chromatography - electrospray ionization mass spectrometry. J. Chromatogr. A 910: 1-11.
62. Parisotto, R., Gore, C., Emslie, K., Ashenden, M., Brugnara, C., Howe, C., Martin, D., Trout, G., et al. (2000). A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes. Haematologica 85: 564-72.
63. Pascual, J., Belalcazar, V., de Bolos, C., Gutierrez, R., Llop, E. and Segura, J. (2004). Recombinant erythropoietin and analogues: A challenge for doping control. Ther. Drug Monit. 26: 175-9.
64. Patel, D. and Greydanus, D. (2002). Genes and athletes. Adolesc. Med. 13: 249-55.
65. Radetti, G., Buzi, F., Tonini, G., Bellone, J., Pagani, S. and Bozzola, M. (2004). Growth hormone (GH) isoforms following acute 22-kDa GH injection: Is it useful to detect GH abuse? Int. J. Sports Med. 25: 205-8.
66. Ranke, M.B., Orskov, H., Bristow, A.F., Seth, J. and Baumann, G. (1999). Consensus on how to measure growth hormone in serum. Horm. Res. 51(Suppl 1): 27-9.
67. Recny, M.A., Scoble, H.A. and Kim, Y. (1987). Structural characterization of natural human urinary and recombinant DNA-derived erythropoietin. Identification of des-arginine 166 erythropoietin. J. Biol. Chem. 262: 17156-63.
68. Reverter, J.L., Tural, C., Rosell, A., Dominguez, M. and Sanmarti, A. (1994). Self-induced insulin hypoglycemia in a bodybuilder. Arch. Intern. Med. 154: 225-6.
69. Rich, J.D., Dickinson, B.P., Merriman, N.A. and Thule, P.M. (1998). Insulin use by bodybuilders. JAMA 279: 1613.
70. Rickert, V., Pawlak-Morello, C., Sheppard, V. and Jay, M. (1992). Human growth hormone: A new substance of abuse among adolescents? Clin Pediat. (Phila). 31: 723-26.
71. Sartorio, A., Agosti, F., Marazzi, N., Maffiuletti, N.A., Cella, S.G., Rigamonti, A.E., Guidetti, L., Di Luigi, L. et al. (2004). Combined evaluation of resting IGF-I, n-terminal propeptide of type III procollagen (pI-IIp) and c-terminal cross-linked telopeptide of type I collagen (ictp) levels might be useful for detecting inappropriate GH administration in athletes: A preliminary report. Clin. Endocrinol. 61: 487-93.
72. Sasaki, H., Bothner, B., Dell, A. and Fukuda, M. (1987). Carbohydrate structure of erythropoietin expressed in chinese hamster ovary cells by a human erythropoietin cdna. J. Biol. Chem. 262: 12059-76.
73. Saugy, M., Cardis, C., Schweizer, C., Veuthey, J. and Rivier, L. (1996). Detection of human growth hormone doping in urine: Out of competition tests are necessary. J. Chromatogr. B Biomed. Appl. 687: 201-11.
74. Schumacher, Y.O. and Ashenden, M. (2004). Doping with artificial oxygen carriers: An update. Sports Med. 34: 141-50.
75. Schumacher, Y.O., Schmid, A., Dinkelmann, S., Berg, A. and Northoff, H. (2001). Artificial oxygen carriers-the new doping threat in endurance sport? Int. J. Sports Med. 22: 566-71.
76. Singh, R.N.P., Seavey, B.K. and Lewis, U.J. (1974). Heterogeneity of human growth hormone. Endocr. Res. Commun. 1: 449-64.
77. Singh, R.N.P., Seavey, B.K. and Lewis, U.J. (1983). Human growth hormone peptide 1-43: Isolation from pituitary glands. J. Protein Chem. 2: 525-36.
78. Sonksen, P.H. (2001). Hormones and sport (insulin, growth hormone and sport). J. Endocrinol. 170: 13-25.
79. Standl, T. (2005). [autologous transfusion - from euphoria to reason: Clinical practice based on scientific knowledge, (part IV). Artificial oxygen carriers: Cell-free hemoglobin solutions - current status 2004]. Anasthesiol. Intensivmed. Notfallmed. Schmerzther. 40: 38-45.
80. Stanley, S.M. and Poljak, A. (2003). Matrix-assisted laser-desorption time-of flight ionisation and high-performance liquid chromatography- electrospray ionisation mass spectral analyses of two glycosylated recombinant epoetins. J. Chromatogr. B 785: 205-18.
81. Steiner, A. and Wagner, R.A. (2002). Insulin. ISP-Verlag, Arnsberg 3: 4-73.
82. Stöcklin, R., Vu, L., Vadas, L., Cerini, F., Kippen, A.D., Offord, R.E. and Rose, K. (1997). A stable isotope dilution assay for the in vivo determination of insulin levels in humans by mass spectrometry. Diabetes 46: 44-50.
83. Stolar, M.W., Amburn, K. and Baumann, G. (1984). Plasma "big" and "big-big" growth hormone (GH) in man: An oligomeric series composed of structurally diverse GH monomers. J. Clin. Endocrinol. Metab. 59: 212-8.
84. Stubiger, G., Marchetti, M., Nagano, M., Reichel, C., Gmeiner, G. and Allmaier, G. (2005). Characterisation of intact recombinant human erythropoietins applied in doping by means of planar gel electrophoretic techniques and matrix-assisted laser desorption/ionisation linear time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 19: 728-42.
85. Sytkowski, A.J. (2004). Erythropoietin - blood, brain and beyond. Wiley-VCH, Weinheim.
86. Thevis, M. and Schanzer, W. (2005). Examples of doping control analysis by liquid chromatography-tandem mass spectrometry: Ephedrines, beta-receptor blocking agents, diuretics, sympathomimetics, and cross-linked hemoglobins. J. Chromatogr. Sci. 43: 22-31.
87. Thevis, M., Ogorzalek-Loo, R.R., Loo, J.A. and Schänzer, W. (2003). Doping control analysis of bovine hemoglobin-based oxygen therapeutics in human plasma by LC-electrospray ionization-MS/MS. Anal. Chem. 75: 3287-93.
88. Thevis, M., Ogorzalek-Loo, R.R., Loo, J.A., Bredehöft, M. and Schänzer, W. (2005a). Probing for characteristics of pituitary growth hormone by lc-ms/ms. In Recent advances in doping analysis, (eds. W. Schänzer, G. Geyer, A. Gotzmann and U. Mareck). Sport & Buch Strauss, Cologne, in press.
89. Thevis, M., Thomas, A., Delahaut, P., Bosseloir, A. and Schanzer, W. (2005b). Qualitative determination of synthetic analogues of insulin in human plasma by immunoaffinity purification and liquid chromatography-tandem mass spectrometry for doping control purposes. Anal. Chem. 77: 3579-85.
90. Vandegriff, K., Malavalli, A., Wooldridge, J., Lohman, J. and Winslow, R. (2003). Mp4, a new nonvasoactive PEG-Hb conjugate. Transfusion 43: 509-16.
91. Varlet-Marie, E., Ashenden, M., Lasne, F., Sicart, M.T., Marion, B., de Ceaurriz, J. and Audran, M. (2004). Detection of hemoglobin-based oxygen carriers in human serum for doping analysis: Confirmation by size-exclusion HPLC. Clin. Chem. 50: 723-31.
92. Videman, T., Lereim, I., Hemmingsson, P., Turner, M.S., Rousseau-Bianchi, M.P., Jenoure, P., Raas, E., Schonhuber, H., et al. (2000). Changes in hemoglobin values in elite cross-country skiers from 1987-1999. Scand. J. Med. Sci. Sports. 10: 98-102.
93. WADA (2004) World Anti-Doping Agency. The 2004 prohibited list, 30-03-2004.
94. Wallace, J.D., Cuneo, R.C., Baxter, R., Orskov, H., Keay, N., Pentecost, C., Dall, R., Rosen, T., et al. (1999). Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: A potential test for GH abuse in sport. J. Clin. Endocrinol. Metab. 84: 3591-601.
95. Wallace, J.D., Cuneo, R.C., Lundberg, P.A., Rosen, T., Jorgensen, J.O., Longobardi, S., Keay, N., Sacca, L., et al. (2000). Responses of markers of bone and collagen turnover to exercise, growth hormone (GH) administration, and GH withdrawal in trained adult males. J. Clin. Endocrinol. Metab. 85: 124-33.
96. Wallace, J.D., Cuneo, R.C., Bidlingmaier, M., Lundberg, P.A., Carlsson, L., Boguszewski, C.L., Hay, J., Boroujerdi, M., et al. (2001). Changes in non-22-kilodalton (kDa) isoforms of growth hormone (GH) after administration of 22-kDa recombinant human GH in trained adult males. J. Clin. Endocrinol. Metab. 86: 1731-7.
97. Wide, L. and Bengtsson, C. (1990). Molecular charge heterogeneity of human serum erythropoietin. Br. J. Haematol. 76: 121-27.
98. Wide, L., Bengtsson, C., Berglund, B. and Ekblom, B. (1995). Detection in blood and urine of recombinant erythropoietin administered to healthy men. Med. Sci. Sports Exerc. 27: 1569-76.
99. Wu, Z., Bidlingmaier, M., Dall, R. and Strasburger, C.J. (1999). Detection of doping with human growth hormone. Lancet 353: 895.
100. Yalow, R.S. and Berson, S.A. (1959). Assay of plasma insulin in human subjects by immunological methods. Nature 184: 1648-9.
101. Yu, Z., Friso, G., Miranda, J.J., Patel, M.J., Lo-Tseng, T., Moore, E.G. and Burlingame, A.L. (1997). Structural characterization of human hemoglobin crosslinked by bis(3,5-dibromosalicyl) fumarate using mass spectrometry techniques. Protein Sci. 6: 2568-77.
102. Zhan, X., Giorgianni, F. and Desiderio, D.M. (2005). Proteomics analysis of growth hormone isoforms in the human pituitary. Proteomics 5: 1228-41.
103. Zhou, G.H., Luo, G.A., Zhou, Y., Zhou, K.Y., Zhang, X.D. and Huang, L.Q. (1998). Application of capillary electrophoresis, liquid chromatography, electrospray-mass spectrometry and matrix-assisted laser desorption/ionization - time of flight - mass spectrometry to the characterization of recombinant human erythropoietin. Electrophoresis 19: 2348-55.